Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
  • Page of 1
Schneider JG, Wood JB, Smith NW, Emery CL, Davis TE, Manaloor JJ, Bocian B, Schmitt BH. Direct antimicrobial susceptibility testing of positive blood cultures: a comparison of the Accelerate Pheno™ and VITEK® 2 systems. Diagn Microbiol Infect Dis. 2019 Nov;95(3):114841. doi: 10.1016/j.diagmicrobio.2019.05.013. Epub 2019 May 29. PubMed PMID: 31422873.
Wood JB, Jones LS, Soper NR, Xu M, Torres VJ, Buddy Creech C, Thomsen IP. Serologic Detection of Antibodies Targeting the Leukocidin LukAB Strongly Predicts Staphylococcus aureus in Children With Invasive Infection. J Pediatric Infect Dis Soc. 2019 May 11;8(2):128-135. doi: 10.1093/jpids/piy017. PubMed PMID: 29538707; PubMed Central PMCID: PMC6510946.
Roberts SC, Jain S, Tremoulet AH, Kim KK, Burns JC, Anand V, Anderson M, Ang J, Ansusinha E, Arditi M, Ashouri N, Bartlett A, Chatterjee A, DeBiasi R, Dekker C, DeZure C, Didion L, Dominguez S, El Feghaly R, Erdem G, Halasa N, Harahsheh A, Jackson MA, Jaggi P, Jain S, Jone PN, Kaushik N, Kurio G, Lillian A, Lloyd D, Manaloor J, McNelis A, Michalik DE, Newburger J, Newcomer C, Perkins T, Portman M, Romero J, Ronis T, Rowley A, Schneider K, Schuster J, Tejtel SKS, Sharma K, Simonsen K, Szmuszkovicz J, Truong D, Wood J, Yeh S. The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease. Contemp Clin Trials. 2019 Apr;79:98-103. doi: 10.1016/j.cct.2019.02.008. Epub 2019 Mar 3. PubMed PMID: 30840903.
Wood JB, Cravens LB, Creech CB. Advances in pediatric antimicrobial agents development. Curr Opin Pediatr. 2019 Feb;31(1):135-143. doi: 10.1097/MOP.0000000000000713. Review. PubMed PMID: 30507647.
Schneider JG, Wood JB, Schmitt BH, Emery CL, Davis TE, Smith NW, Blevins S, Hiles J, Desai A, Wrin J, Bocian B, Manaloor JJ. Susceptibility Provision Enhances Effective De-escalation (SPEED): utilizing rapid phenotypic susceptibility testing in Gram-negative bloodstream infections and its potential clinical impact. J Antimicrob Chemother. 2019 Jan 1;74(Suppl 1):i16-i23. doi: 10.1093/jac/dky531. PubMed PMID: 30690542; PubMed Central PMCID: PMC6382035.
Wood JB, Fricker GP, Beekmann SE, Polgreen P, Buddy Creech C. Practice Patterns of Providers for the Management of Staphylococcus aureus Bacteremia in Children: Results of an Emerging Infections Network Survey. J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):e152-e155. doi: 10.1093/jpids/piy022. PubMed PMID: 29534244; PubMed Central PMCID: PMC7372959.
Frazier SB, Katz S, Wood JB, Cassat JE. An Unusual Source of Sepsis in Two Previously Healthy Children. Clin Pediatr (Phila). 2018 Aug;57(9):1120-1122. doi: 10.1177/0009922817738349. Epub 2017 Oct 30. PubMed PMID: 29084446; PubMed Central PMCID: PMC5878989.
Wood JB, Sesler C, Stalons D, Grigorenko E, Schoenecker JG, Creech CB, Thomsen IP. Performance of TEM-PCR vs Culture for Bacterial Identification in Pediatric Musculoskeletal Infections. Open Forum Infect Dis. 2018 Jun 1;5(6):ofy119. doi: 10.1093/ofid/ofy119. eCollection 2018 Jun 1. PubMed PMID: 29977969; PubMed Central PMCID: PMC6007387.
Wood JB, Jones LS, Soper NR, Nagarsheth M, Creech CB, Thomsen IP. Commercial Intravenous Immunoglobulin Preparations Contain Functional Neutralizing Antibodies against the Staphylococcus aureus Leukocidin LukAB (LukGH). Antimicrob Agents Chemother. 2017 Nov;61(11). doi: 10.1128/AAC.00968-17. Print 2017 Nov. PubMed PMID: 28874371; PubMed Central PMCID: PMC5655085.
Thomsen IP, Sapparapu G, James DBA, Cassat JE, Nagarsheth M, Kose N, Putnam N, Boguslawski KM, Jones LS, Wood JB, Creech CB, Torres VJ, Crowe JE Jr. Monoclonal Antibodies Against the Staphylococcus aureus Bicomponent Leukotoxin AB Isolated Following Invasive Human Infection Reveal Diverse Binding and Modes of Action. J Infect Dis. 2017 Apr 1;215(7):1124-1131. doi: 10.1093/infdis/jix071. PubMed PMID: 28186295; PubMed Central PMCID: PMC5426380.
An TJ, Benvenuti MA, Mignemi ME, Martus J, Wood JB, Thomsen IP, Schoenecker JG. Similar Clinical Severity and Outcomes for Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Pediatric Musculoskeletal Infections. Open Forum Infect Dis. 2017 Winter;4(1):ofx013. doi: 10.1093/ofid/ofx013. eCollection 2017 Winter. PubMed PMID: 28480284; PubMed Central PMCID: PMC5414090.
Reese T, Villegas L, Wood J, Gotte A. A 21-Month-Old Male With Refusal to Walk, Rash, and Weight Loss. Arthritis Care Res (Hoboken). 2017 Feb;69(2):286-293. doi: 10.1002/acr.22792. PubMed PMID: 26606665.
Wood JB, Thomsen IP, Creech CB, Newland JG. Best Practices for Treatment of Invasive Methicillin-Susceptible Staphylococcus aureus Infections: The Case for Oxacillin. J Pediatric Infect Dis Soc. 2016 Dec;5(4):480-482. doi: 10.1093/jpids/piw052. Epub 2016 Sep 7. PubMed PMID: 27609072.
Wood JB, Johnson DP. Prolonged intravenous instead of oral antibiotics for acute hematogenous osteomyelitis in children. J Hosp Med. 2016 Jul;11(7):505-8. doi: 10.1002/jhm.2549. Review. PubMed PMID: 27373702.
What would you like to do?
  • Page of 1